Benzodiazepines, commonly called benzos, are a class of prescription sedatives that slow down brain activity. There are roughly 15 benzodiazepines approved for use in the United States, and they’re prescribed for conditions ranging from anxiety and insomnia to seizures and muscle spasms. The most widely recognized names include Xanax (alprazolam), Valium (diazepam), Ativan (lorazepam), and Klonopin (clonazepam).
Full List of Benzodiazepines
The FDA recognizes the following benzodiazepines, each sold under one or more brand names:
- Alprazolam (Xanax, Xanax XR)
- Chlordiazepoxide (Librium)
- Clobazam (Onfi)
- Clonazepam (Klonopin)
- Clorazepate (Tranxene, Gen-Xene)
- Diazepam (Valium, Diastat)
- Estazolam (no brand currently marketed)
- Flurazepam (no brand currently marketed)
- Lorazepam (Ativan)
- Midazolam (used primarily in hospital settings)
- Oxazepam (no brand currently marketed)
- Quazepam (Doral)
- Temazepam (Restoril)
- Triazolam (Halcion)
Some of these are also available in combination products. Chlordiazepoxide, for example, is combined with other medications and sold as Librax or Limbitrol.
How Benzos Work in the Brain
All benzodiazepines work by amplifying the effects of GABA, a chemical messenger that tells your brain to calm down. Normally, GABA attaches to its receptor and opens a channel that lets ions flow in, quieting nerve activity. Benzos don’t activate that receptor directly. Instead, they latch onto a nearby spot on the same receptor and change its shape so it responds more strongly to the GABA already present. Think of it like loosening a faucet handle: the water (GABA) is already there, but the drug makes it flow more easily.
This is why benzos produce a broad set of effects: less anxiety, muscle relaxation, drowsiness, and suppressed seizure activity. It’s also why they don’t work well without GABA in the picture. They enhance something your brain is already doing rather than creating an entirely new chemical signal.
What Benzos Are Prescribed For
Doctors prescribe benzodiazepines for a handful of overlapping conditions, though not every benzo is used for every purpose. Anxiety disorders are the most common reason, and alprazolam, lorazepam, and clonazepam are among the most frequently prescribed for this. Diazepam and clonazepam are also used to control seizures, while diazepam doubles as a muscle relaxant. For insomnia, the go-to options are temazepam, triazolam, flurazepam, and quazepam, which are designed to help with sleep onset or staying asleep. Midazolam is typically used before medical procedures to provide sedation and reduce anxiety.
The specific benzo a doctor chooses depends largely on how quickly it kicks in and how long its effects last.
Short-Acting vs. Long-Acting Benzos
Benzodiazepines are grouped by how long they stay active in your body, measured by their elimination half-life (the time it takes for half the drug to clear your system).
- Short-acting (1 to 12 hours): Triazolam and midazolam fall here. They hit fast and wear off quickly, making them useful for sleep or brief procedures.
- Intermediate-acting (12 to 40 hours): Alprazolam, lorazepam, temazepam, and oxazepam are in this range. They’re commonly prescribed for anxiety because they last long enough to provide relief through a chunk of the day.
- Long-acting (40 to 250 hours): Diazepam, chlordiazepoxide, clorazepate, and flurazepam can linger in your system for days. Diazepam, for instance, produces active byproducts as your liver processes it, extending its effects well beyond a single dose.
This matters in practice. A short-acting benzo might help you fall asleep without leaving you groggy the next morning, while a long-acting one provides steadier coverage for conditions like seizure disorders. The tradeoff is that long-acting benzos can build up in the body over time, especially in older adults whose livers metabolize drugs more slowly.
How Potency Differs Between Benzos
Not all benzos are dosed the same way. Some are far more potent milligram for milligram. Clonazepam and alprazolam, for example, produce roughly the same effect at 0.25 to 1 mg that diazepam produces at 5 to 10 mg. On the other end, you might need 15 to 30 mg of oxazepam or flurazepam to achieve a similar effect. This doesn’t mean one drug is “stronger” in a meaningful way. It just means the pills come in different concentrations. Your doctor adjusts the dose so the actual effect on your body is comparable.
Where potency does matter is in accidental overdose or switching between medications. Confusing the dose of a high-potency benzo like clonazepam with a low-potency one like oxazepam could mean taking many times the intended effect.
Dependence and Withdrawal
Benzodiazepines carry a real risk of physical dependence, even when taken exactly as prescribed. Your brain adapts to the enhanced GABA activity over time, and removing the drug abruptly can cause a rebound effect. The FDA now requires a boxed warning on all benzodiazepines highlighting the risks of abuse, misuse, addiction, and physical dependence.
Withdrawal typically follows one of two patterns. The more common one is a short-lived rebound of the original symptoms, mainly anxiety and insomnia, starting within one to four days after stopping. How quickly symptoms appear depends on whether you were taking a short-acting or long-acting benzo. Short-acting drugs like triazolam produce withdrawal sooner, often within a day, while long-acting drugs like diazepam may not trigger symptoms for several days.
The second pattern is a full withdrawal syndrome lasting 10 to 14 days, which can include irritability, sweating, difficulty concentrating, tremors, and in severe cases, seizures. Withdrawal tends to be more intense after high doses or after stopping short-acting benzos. This is why doctors generally taper the dose gradually rather than stopping cold.
Legal Classification
All prescription benzodiazepines are Schedule IV controlled substances under federal law, meaning they have recognized medical use but carry a risk of dependence. Schedule IV is a relatively moderate classification compared to drugs like opioids (Schedule II) or stimulants like amphetamines.
Several newer, non-prescription benzodiazepine variants that have appeared in the illicit drug supply are treated differently. As of 2025, the DEA finalized the placement of five designer benzodiazepines, including clonazolam, etizolam, and flualprazolam, into Schedule I. Schedule I drugs have no accepted medical use and carry severe penalties for possession or distribution. These substances are often far more potent than prescription benzos and are a growing factor in overdose deaths, particularly when mixed with opioids like fentanyl.